CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383982704
- Phone
- 6096193990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- UPLOAD Other SEC-generated Letter
- CT ORDER Other Confidential Order
- SEC STAFF ACTION Other SEC Staff Action
- S-1 Offering Registration Statement
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
- POS AM Other Post-effective Amendment for Registration Statement
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Shareholder rights changed · Other events
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 29 of 42 · 833 filings